close_game
close_game

serum institute

Latest from serum institute

Adar Poonawalla speaks out on work-life balance: 'Can't go beyond 8-9 hours'

The Serum CEO said that meeting people and building relationships, for charity or networking purposes, is as crucial as office hours.

Adar Poonawalla said that just working in office from Monday to Sunday is a
Updated on Jan 23, 2025 12:43 PM IST

‘Disclosed all rare side effects’: SII clarifies amid vaccine safety row

In India, the Serum Institute of India (SII) said it stopped the manufacturing of additional doses of Covishield since December 2021.

A vial of the Covishield vaccine. (HT File Photo)
Published on May 08, 2024 07:55 PM IST

Afternoon briefing: Delhi Police's ‘fake msgs’ warning

The shortlist of biggest headlines, recommended stories, and special collection of news items you should check out.

Delhi school bomb threat news: Police and fire department personnel outside Mother Mary's School at Mayur Vihar, in New Delhi on Wednesday( (PTI Photo/Ravi Choudhary) )
Published on May 02, 2024 01:25 PM IST

Covovax to be available on CoWIN as booster dose soon. Check details

Covovax is likely to be available on the portal in a few days at a price of ₹225 per dose plus applicable GST.

Covovax can be administered to those who have already vaccinated with Covishield or Covaxin. (AFP)
Published on Apr 10, 2023 05:00 PM IST
PTI |

Oxford, Serum initiative: Anti-malaria vaccine’s Phase 3 trials conclude

The R21 malaria vaccine, which is also known as Matrix-M, was designed at the Jenner Institute, University of Oxford, which collaborated with SII in 2020 to manufacture and develop the jab for large-scale supply.

According to WHO, malaria is a life-threatening disease caused by Plasmodium parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes.
Published on Dec 06, 2022 08:33 AM IST
By, New Delhi
Story Saved
Live Score
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Wednesday, May 07, 2025
Follow Us On